… pathologies in children lead to increased off-label use of rituximab. We … B lymphocytes (CD19+)
under treatment with intravenous rituximab in children with neurologic and autoimmune …

… Pharmacodynamics of rituximab on B lymphocytes in paediatric patients with autoimmune
… antibodies in autoimmune disease treatment. Auto Immun Highlights 2017; 8: 12. 38. …

… autoimmune conditions affecting adult and pediatric patients. An … of rituximab in pediatric
patients with GPA/MPA. To determine the selection of an appropriate dose regimen in children …

… not significantly differ between paediatric patient groups. Severe … In other autoimmune
diseases, such as systemic lupus … B cell depletion has been reported in various adult patients (6, 7)…

… found rituximab to be effective for other autoimmune diseases … on all B-lineage cells other
than precursor B cells and … Pharmacokinetics of rituximab in a pediatric patient with therapy-…

… autoimmune diseases and alloimmune responses after transplantation. It depletes the
disease-causing B cells … bone marrow transplantation, pediatric immunology and pharmacology. …

… lineage including pre-B cells, memory cells and B lymphocytes found in tissues such …
Pharmacodynamics of rituximab on B lymphocytes in paediatric patients with autoimmune diseases…

… evaluating the pharmacokinetic/pharmacodynamic activity of … rituximab a more affordable,
and potentially the only B cell-… , performed in pediatric patients with autoimmune disorders, …

… the effect of rituximab on eliminating B lymphocytes in the treatment of pediatric patients with
… dosing regimens that provide adequate suppression of B lymphocytes (below 10 × 10 6 /L) …

… to T cells through interaction between the T cell receptor and … in rituximab-administered
patients with autoimmune diseases … , and pharmacodynamics between RTXM83™, a rituximab …